Polifarma was honored as “Best enterprise in the environment sector for management performance and financial reliability Cerved headquartered in the Lazio region” during the 51st Industria Felix event. The award ceremony was organized by Industria Felix Magazine, in co-organization with the Region of Umbria, with the collaboration of Cerved, Luiss Guido Carli University, A.C. Industria Felix, Confindustria, and the patronage of Simest, the Municipality of Foligno, Banca Mediolanum, Mediolanum Private Banking, Grant Thornton, ELITE (Euronext Group), Plus Innovation, and M&L Consulting Group.
Councillor for European Planning, Budget and Human Resources and Assets, Tourism, Culture, Education and Right to Study of the Region of Umbria, Paola Agabiti, said the Industria Felix Award is an important recognition for all the companies that have distinguished themselves and is a driving force for the territory that hosts them.
“Financial reliability is a crucial element for the development and success of a company” – Andrea Bracci, CEO of Polifarma, commented with satisfaction on the sidelines of the event. “It denotes the ability to manage the company aimed at creating the best conditions for development without generating financial disequilibrium, which represents the greatest element of risk for a company’s ambitions or survival”.
The awarding of Polifarma Spa represents an important recognition for the company and the territory that hosts it and is an example of how financial balances are a fundamental lever for the development of a company that looks to the future with renewed ambitions.
“Our reality”, continues Bracci, “thanks also to the budget policies outlined by our President, Luisa Angelini, manages to generate profitability and at the same time reinvest it in new development projects. This policy, a rarity in the national industrial context, has enabled our reality to make significant investments in recent years, generating development well above the growth of our target market. The most representative figure of what has been expressed above is the value of our Shareholders’ Equity, which, with its 65% of Sources, highlights our excellent solidity. Important values, the result of company policy, but also of the great work of so many employees (women 48% – men 52%) whose extraordinary daily work has contributed to the achievement of these brilliant results. We are among the companies in our industry most focused on the development of bio-digital solutions that represent the future of health for our patients. Our investments, all the result of the company’s financial capacity, will continue in the direction of generating growth and evolution of our reality that has been on the market for more than 100 years. Ideas, investments, people, and innovation are therefore the key elements to look to the future with optimism, but everything must always be accomplished without neglecting the financial balances that are the fundamental lever for the development of a company that looks to the future with renewed ambitions”.